Urban J, Vaisar T, Shen R, Lee M S
Molecumetics Ltd., Bellevue, Washington, USA.
Int J Pept Protein Res. 1996 Mar;47(3):182-9. doi: 10.1111/j.1399-3011.1996.tb01343.x.
Trifluoroacetic acid (TFA) is a common reagent in both solid-phase and solution peptide synthesis. It is used for the deprotection and/or cleavage of the synthesized peptide from the resin. The use of TFA under these standardized conditions is thought to be sufficiently mild, thereby preventing degradation of the desired product. However, peptides of the general structure R1-(N-alkyl X1)-X2-R2 are hydrolyzed by standard TFA solid-phase peptide synthesis (SPPS) cleavage/deprotection conditions providing fragments R1-(N-alkyl X1)-OH and H-X2-R2. The fragmentation is observed during a TFA cleavage both from the resin and in solution. The hydrolysis is proposed to proceed via an oxazolone-like intermediate in which equilibration of the chiral center of the N-alkylated residue occurs. This mechanism is supported by H/D exchange as observed MS and NMR in conjunction with HPLC.
三氟乙酸(TFA)是固相和溶液相肽合成中常用的试剂。它用于从树脂上脱保护和/或切割合成的肽。在这些标准化条件下使用TFA被认为足够温和,从而防止所需产物的降解。然而,一般结构为R1-(N-烷基X1)-X2-R2的肽会在标准TFA固相肽合成(SPPS)切割/脱保护条件下发生水解,生成片段R1-(N-烷基X1)-OH和H-X2-R2。在从树脂上进行TFA切割以及在溶液中时均观察到了这种片段化现象。有人提出水解是通过类似恶唑酮的中间体进行的,其中N-烷基化残基的手性中心会发生平衡。通过结合HPLC观察到的MS和NMR中的H/D交换支持了这一机制。